FDA Recalls Tandem Diabetes Care’s t:connect Mobile App Due to Potential Health Risks
Insulin Pump App Malfunction Leads to Serious Safety Concerns The U.S. Food and Drug Administration (FDA) has issued a Class I recall, the most severe type of recall, for version 2.7 of Tandem Diabetes Care, Inc.’s t:connect mobile app. The app, which pairs with the t:slim X2 insulin pump with Control IQ technology, has caused...
Published on May 15, 2024